Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kosuke Yoshihara

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
Cancer Science|July 10, 2026
AI-Based Analysis of Tumor-Infiltrating Lymphocytes and Homologous Recombination in Ovarian Cancer: JGOG3025-A1 StudyKohei Hamada, Junzo Hamanishi, Noriomi Matsumura, et al.
Gynecologic Oncology|August 28, 2021
Proposing a molecular classification associated with hypercoagulation in ovarian clear cell carcinomaRyo Tamura, Kosuke Yoshihara, Koji Matsuo, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 17, 2017
In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancerMichiko Kodama, Takahiro Kodama, Justin Y Newberg, et al.
Nature Communications|February 18, 2022
Spatiotemporal dynamics of clonal selection and diversification in normal endometrial epitheliumManako Yamaguchi, Hirofumi Nakaoka, Kazuaki Suda, et al.
Molecular Cancer Therapeutics|September 17, 2023
SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian CarcinomaHidehiko Akashi, Nozomi Yachida, Haruka Ueda, et al.
Nature Communications|October 12, 2013
Inferring tumour purity and stromal and immune cell admixture from expression dataKosuke Yoshihara, Maria Shahmoradgoli, Emmanuel Martínez, et al.
Oncogene|March 3, 2020
XCL1 expression correlates with CD8-positive T cells infiltration and PD-L1 expression in squamous cell carcinoma arising from mature cystic teratoma of the ovaryRyo Tamura, Kosuke Yoshihara, Hirofumi Nakaoka, et al.
The Journal of Dermatology|November 2, 2024
Reevaluating hybrid neurofibroma/schwannoma: Predominance of schwannoma features despite CD34 positivity and initial neurofibroma diagnosisTatsuya Katsumi, Ryota Hayashi, Shingo Takei, et al.
The American Journal of Pathology|March 20, 2016
Establishment of a Novel Histopathological Classification of High-Grade Serous Ovarian Carcinoma Correlated with Prognostically Distinct Gene Expression SubtypesRyusuke Murakami, Noriomi Matsumura, Masaki Mandai, et al.
Oncogene|December 16, 2017
The impact of stromal Hic-5 on the tumorigenesis of colorectal cancer through lysyl oxidase induction and stromal remodelingTomokatsu Omoto, Joo-Ri Kim-Kaneyama, Xiao-Feng Lei, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Cancer Science|July 10, 2026
AI-Based Analysis of Tumor-Infiltrating Lymphocytes and Homologous Recombination in Ovarian Cancer: JGOG3025-A1 StudyKohei Hamada, Junzo Hamanishi, Noriomi Matsumura, et al.
Gynecologic Oncology|August 28, 2021
Proposing a molecular classification associated with hypercoagulation in ovarian clear cell carcinomaRyo Tamura, Kosuke Yoshihara, Koji Matsuo, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 17, 2017
In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancerMichiko Kodama, Takahiro Kodama, Justin Y Newberg, et al.
Nature Communications|February 18, 2022
Spatiotemporal dynamics of clonal selection and diversification in normal endometrial epitheliumManako Yamaguchi, Hirofumi Nakaoka, Kazuaki Suda, et al.
Molecular Cancer Therapeutics|September 17, 2023
SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian CarcinomaHidehiko Akashi, Nozomi Yachida, Haruka Ueda, et al.
Nature Communications|October 12, 2013
Inferring tumour purity and stromal and immune cell admixture from expression dataKosuke Yoshihara, Maria Shahmoradgoli, Emmanuel Martínez, et al.
Oncogene|March 3, 2020
XCL1 expression correlates with CD8-positive T cells infiltration and PD-L1 expression in squamous cell carcinoma arising from mature cystic teratoma of the ovaryRyo Tamura, Kosuke Yoshihara, Hirofumi Nakaoka, et al.
The Journal of Dermatology|November 2, 2024
Reevaluating hybrid neurofibroma/schwannoma: Predominance of schwannoma features despite CD34 positivity and initial neurofibroma diagnosisTatsuya Katsumi, Ryota Hayashi, Shingo Takei, et al.
The American Journal of Pathology|March 20, 2016
Establishment of a Novel Histopathological Classification of High-Grade Serous Ovarian Carcinoma Correlated with Prognostically Distinct Gene Expression SubtypesRyusuke Murakami, Noriomi Matsumura, Masaki Mandai, et al.
Oncogene|December 16, 2017
The impact of stromal Hic-5 on the tumorigenesis of colorectal cancer through lysyl oxidase induction and stromal remodelingTomokatsu Omoto, Joo-Ri Kim-Kaneyama, Xiao-Feng Lei, et al.
Pageof 13